newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results

Q2 Revenue of $9.1 millionQ2 Income from Continuing Operations of $0.3 millionQ2 Thyroid volume year-over-year increase of 6%Q2 Thyroid revenue year-over-year increase of 9%Trailing twelve-month thyroid revenue of $36.1